首页 > 最新文献

Neurogastroenterology and Motility最新文献

英文 中文
Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label study. 利那洛肽治疗耐药性慢性便秘的有效性和安全性:一项多中心、开放标签研究。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-06 DOI: 10.1111/nmo.14938
Tsutomu Yoshihara, Takaomi Kessoku, Tomohiro Takatsu, Noboru Misawa, Keiichi Ashikari, Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Michihiro Iwaki, Takeo Kurihashi, Machiko Nakatogawa, Koji Yamamoto, Izuru Terada, Yusuke Tanaka, Masataka Morita, Atsushi Nakajima

Background: This study aimed to evaluate the efficacy and safety of linaclotide in patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C) who did not respond to treatment with magnesium oxide (MgO).

Methods: This study was designed as a multicenter, open-label, single-arm, exploratory study. Patients with CC or IBS-C who took MgO and those meeting the medication initiation criteria were administered linaclotide at a daily dosage of 500 μg for 12 weeks. The primary endpoint was a change in the Japanese version of the Patient Assessment of Constipation Quality of Life (JPAC-QOL) score from baseline, which was evaluated by using a paired t-test.

Key results: The patients' mean age (± standard deviation) was 67.6 ± 13.82 years. The full analysis set included 61 patients. The JPAC-QOL total score was 1.60 at baseline and 0.70 at 12 weeks, with a significant mean change of -0.89 ± 0.721 (p < 0.001). Several secondary endpoints also showed improvement. The frequency of spontaneous bowel movement (SBM) and complete SBM increased by 2.70 ± 7.254 (p < 0.01) and 2.81 ± 5.254 times, respectively (p < 0.001). The Bristol Stool Form Scale, abdominal bloating severity, and straining severity scores improved by 1.33 ± 1.274 (p < 0.001), -0.16 ± 0.563 (p < 0.05), and -0.46 ± 0.795 (p < 0.001) points, respectively. The safety analysis set included 65 patients, 7 of whom had diarrhea, which improved with dose reduction and drug withdrawal.

Conclusion & inferences: The study was conducted in an older adult population, similar to real clinical practice. Linaclotide may be an option for treating CC that shows an inadequate response to conventional therapy.

研究背景本研究旨在评估利那洛肽对使用氧化镁(MgO)治疗无效的慢性便秘(CC)或伴便秘的肠易激综合征(IBS-C)患者的疗效和安全性:本研究是一项多中心、开放标签、单臂、探索性研究。服用过氧化镁的CC或IBS-C患者以及符合药物治疗起始标准的患者均接受了利那洛肽治疗,每日剂量为500微克,为期12周。主要研究终点为日文版便秘患者生活质量评估(JPAC-QOL)评分与基线相比的变化,采用配对t检验进行评估:主要结果:患者的平均年龄(± 标准差)为 67.6±13.82 岁。完整的分析集包括 61 名患者。JPAC-QOL 总分在基线时为 1.60,12 周时为 0.70,平均变化显著为 -0.89 ± 0.721(p 结论与推论:该研究在老年人群中进行,与实际临床实践相似。利那洛肽可能是治疗对常规疗法反应不佳的CC的一种选择。
{"title":"Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label study.","authors":"Tsutomu Yoshihara, Takaomi Kessoku, Tomohiro Takatsu, Noboru Misawa, Keiichi Ashikari, Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Michihiro Iwaki, Takeo Kurihashi, Machiko Nakatogawa, Koji Yamamoto, Izuru Terada, Yusuke Tanaka, Masataka Morita, Atsushi Nakajima","doi":"10.1111/nmo.14938","DOIUrl":"10.1111/nmo.14938","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the efficacy and safety of linaclotide in patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C) who did not respond to treatment with magnesium oxide (MgO).</p><p><strong>Methods: </strong>This study was designed as a multicenter, open-label, single-arm, exploratory study. Patients with CC or IBS-C who took MgO and those meeting the medication initiation criteria were administered linaclotide at a daily dosage of 500 μg for 12 weeks. The primary endpoint was a change in the Japanese version of the Patient Assessment of Constipation Quality of Life (JPAC-QOL) score from baseline, which was evaluated by using a paired t-test.</p><p><strong>Key results: </strong>The patients' mean age (± standard deviation) was 67.6 ± 13.82 years. The full analysis set included 61 patients. The JPAC-QOL total score was 1.60 at baseline and 0.70 at 12 weeks, with a significant mean change of -0.89 ± 0.721 (p < 0.001). Several secondary endpoints also showed improvement. The frequency of spontaneous bowel movement (SBM) and complete SBM increased by 2.70 ± 7.254 (p < 0.01) and 2.81 ± 5.254 times, respectively (p < 0.001). The Bristol Stool Form Scale, abdominal bloating severity, and straining severity scores improved by 1.33 ± 1.274 (p < 0.001), -0.16 ± 0.563 (p < 0.05), and -0.46 ± 0.795 (p < 0.001) points, respectively. The safety analysis set included 65 patients, 7 of whom had diarrhea, which improved with dose reduction and drug withdrawal.</p><p><strong>Conclusion & inferences: </strong>The study was conducted in an older adult population, similar to real clinical practice. Linaclotide may be an option for treating CC that shows an inadequate response to conventional therapy.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14938"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary behavioral therapy reduces rumination. 多学科行为疗法可减少反刍。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-20 DOI: 10.1111/nmo.14919
M Nyyssönen, O Vilpponen, M Ståhl-Railila, S Liesto, T Mustonen, S Pikkarainen, P Arkkila, R Roine, H Sintonen, J Punkkinen

Background: Behavioral therapy has proved effective as rumination therapy. Our objective was to treat rumination patients using multidisciplinary behavioral therapy aimed at reducing ≥2 of the rumination score.

Methods: All patients fulfilled Rome IV criteria for rumination and were referred to speech therapy for psychoeducation, diaphragmatic breathing exercises and guided eating, physiotherapy for exercises to relax the thoracic and abdominal muscles, and consultation with the psychologist and the dietitian. Symptoms, depression, anxiety, health-related quality of life (HRQoL), and functional capacity were evaluated by questionnaires (Rome IV, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), 15D, and World Health Organization Disability Assessment Schedule (WHODAS) 2.0) at baseline and at 6-month control. Esophageal manometry was performed at 6-month control.

Key results: The study enrolled 11 patients (19-64 years, 10 female). Rumination score: 6.5 (5-8) at baseline, 4.0 (3-5) at the 6-month control, p = 0.005. BDI/8 (6-13), BAI/15 (8-29) at baseline; BDI/7 (4-8), BAI/15 (7-27) at the 6-month control, NS. 15D score: 0.800 at baseline, 0.845 at the 6-month control, NS. WHODAS 2.0 score: 15 (7-33) at baseline, 11 (7-26) at the 6-month control, NS. Rumination could be evoked in manometry in six of nine (67%) patients at 6-month control.

Conclusions and inferences: Behavioral multidisciplinary therapy significantly reduces the self-assessed frequency of rumination. These patients have more depression, anxiety and a lower HRQoL compared to the normal population.

背景:行为疗法已被证明是有效的反刍疗法。我们的目标是采用多学科行为疗法治疗反刍患者,旨在减少≥2的反刍评分:所有患者均符合罗马IV标准的反刍症状,并转诊至言语治疗中心接受心理教育、横膈膜呼吸练习和饮食指导,物理治疗中心进行胸肌和腹肌放松练习,并咨询心理学家和营养师。在基线和6个月控制期间,通过问卷(罗马IV、贝克抑郁量表(BDI)、贝克焦虑量表(BAI)、15D和世界卫生组织残疾评估表(WHODAS)2.0)对症状、抑郁、焦虑、健康相关生活质量(HRQoL)和功能能力进行了评估。在6个月对照组时进行食管测压:研究共招募了 11 名患者(19-64 岁,10 名女性)。反刍评分:基线时为 6.5(5-8),6 个月对照时为 4.0(3-5),P = 0.005。基线时 BDI/8(6-13),BAI/15(8-29);6 个月对照时 BDI/7(4-8),BAI/15(7-27),NS。15D 评分:基线时为 0.800,6 个月对照时为 0.845,NS。WHODAS 2.0 评分:基线时为 15(7-33),6 个月对照时为 11(7-26),NS。9名患者中有6名(67%)在6个月的对照组中能通过测压唤起反刍:结论与推论:多学科行为疗法可显著降低自评的反刍频率。与正常人群相比,这些患者的抑郁、焦虑程度更高,HRQoL 更低。
{"title":"Multidisciplinary behavioral therapy reduces rumination.","authors":"M Nyyssönen, O Vilpponen, M Ståhl-Railila, S Liesto, T Mustonen, S Pikkarainen, P Arkkila, R Roine, H Sintonen, J Punkkinen","doi":"10.1111/nmo.14919","DOIUrl":"10.1111/nmo.14919","url":null,"abstract":"<p><strong>Background: </strong>Behavioral therapy has proved effective as rumination therapy. Our objective was to treat rumination patients using multidisciplinary behavioral therapy aimed at reducing ≥2 of the rumination score.</p><p><strong>Methods: </strong>All patients fulfilled Rome IV criteria for rumination and were referred to speech therapy for psychoeducation, diaphragmatic breathing exercises and guided eating, physiotherapy for exercises to relax the thoracic and abdominal muscles, and consultation with the psychologist and the dietitian. Symptoms, depression, anxiety, health-related quality of life (HRQoL), and functional capacity were evaluated by questionnaires (Rome IV, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), 15D, and World Health Organization Disability Assessment Schedule (WHODAS) 2.0) at baseline and at 6-month control. Esophageal manometry was performed at 6-month control.</p><p><strong>Key results: </strong>The study enrolled 11 patients (19-64 years, 10 female). Rumination score: 6.5 (5-8) at baseline, 4.0 (3-5) at the 6-month control, p = 0.005. BDI/8 (6-13), BAI/15 (8-29) at baseline; BDI/7 (4-8), BAI/15 (7-27) at the 6-month control, NS. 15D score: 0.800 at baseline, 0.845 at the 6-month control, NS. WHODAS 2.0 score: 15 (7-33) at baseline, 11 (7-26) at the 6-month control, NS. Rumination could be evoked in manometry in six of nine (67%) patients at 6-month control.</p><p><strong>Conclusions and inferences: </strong>Behavioral multidisciplinary therapy significantly reduces the self-assessed frequency of rumination. These patients have more depression, anxiety and a lower HRQoL compared to the normal population.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14919"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of deglutitive striated esophagus motor function and pharyngeal phase swallowing biomechanical events. 脱落横纹食管运动功能与咽相吞咽生物力学事件的相关性。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-20 DOI: 10.1111/nmo.14920
Reza Shaker, Mark Kern, Francis Edeani, Ling Mei, Elliot Yu, Patrick Sanvanson

Background: The functional relationship of striated esophagus (St.Eso) motor function with pharyngeal deglutitive biomechanical events has not been systematically studied. The aim of this study was to determine the spatio-temporal characteristics of St.Eso function and its correlation with pharyngeal biomechanics and bolus transport.

Methods: We studied 50 healthy volunteer subjects (age range: 21-82 years, 31 female) by digital videofluoroscopy. All subjects were studied in a seated, upright position. Thirteen of these 50 volunteers also underwent high-resolution manometry (HRM) concurrent with fluoroscopy. We used laryngeal excursion as a surrogate for St.Eso excursion.

Key results: Median duration of St.Eso excursion was 2.35 [1.93,2.85, 5th and 95th percentile] seconds. Mean maximum extent of St.Eso excursion was 2.84 ± 0.72 cm. We identified four distinct periods in deglutitive St.Eso motor function: P1. Anterosuperior ascent without bolus or peristaltic activity, P2. Non-peristaltic bolus receiving at the apogee of St.Eso excursion concurrent with UES opening and pharyngeal peristalsis P3. Peristaltic bolus transport as St.Eso descends and P4. Continued peristalsis in resting position.

Conclusions and inferences: 1. St.Eso motor function spans both pharyngeal and esophageal phases of swallowing for receiving and transporting the bolus, 2. Pressure signatures in HRM recordings currently attributed to St.Eso deglutitive motor activity does not represent the entirety of St.Eso peristalsis, only the part that occurs in its resting position. St.Eso peristalsis that occurs during its descent is recorded by pressure sensors initially in the pharynx. This finding needs to be considered when interpreting HRM recordings of the pharynx and proximal esophagus.

背景:尚未系统研究横纹肌食管(St.Eso)运动功能与咽脱落生物力学事件之间的功能关系。本研究的目的是确定 St.Eso 功能的时空特征及其与咽部生物力学和药栓运输的相关性:我们通过数字视频荧光屏对 50 名健康志愿者(年龄范围:21-82 岁,女性 31 人)进行了研究。所有受试者均采取坐姿和直立姿势进行研究。这 50 名志愿者中有 13 人在接受透视检查的同时还接受了高分辨率测压(HRM)检查。我们用喉偏移来替代 St.Eso 偏移:主要结果:St.Eso偏移的中位持续时间为2.35秒[1.93,2.85,第5和第95百分位数]。St.Eso 偏移的平均最大范围为 2.84 ± 0.72 厘米。我们确定了 St.Eso 运动功能的四个不同时期:P1.无栓塞或蠕动活动的前上行;P2.在 St.Eso 运动的远端接收非蠕动栓子,同时上咽部开口和咽部蠕动;P3.在 St.Eso 下降时蠕动输送栓子,P4.在静息位置继续蠕动:1.圣埃索运动功能横跨吞咽的咽部和食管阶段,用于接收和运送栓子,2. 目前认为圣埃索脱髓鞘运动活动所产生的 HRM 记录中的压力信号并不代表圣埃索蠕动的全部,只代表在静息位置发生的部分。St.Eso 在下降过程中发生的蠕动最初是由咽部的压力传感器记录的。在解释咽部和食管近端 HRM 记录时需要考虑这一发现。
{"title":"Correlation of deglutitive striated esophagus motor function and pharyngeal phase swallowing biomechanical events.","authors":"Reza Shaker, Mark Kern, Francis Edeani, Ling Mei, Elliot Yu, Patrick Sanvanson","doi":"10.1111/nmo.14920","DOIUrl":"10.1111/nmo.14920","url":null,"abstract":"<p><strong>Background: </strong>The functional relationship of striated esophagus (St.Eso) motor function with pharyngeal deglutitive biomechanical events has not been systematically studied. The aim of this study was to determine the spatio-temporal characteristics of St.Eso function and its correlation with pharyngeal biomechanics and bolus transport.</p><p><strong>Methods: </strong>We studied 50 healthy volunteer subjects (age range: 21-82 years, 31 female) by digital videofluoroscopy. All subjects were studied in a seated, upright position. Thirteen of these 50 volunteers also underwent high-resolution manometry (HRM) concurrent with fluoroscopy. We used laryngeal excursion as a surrogate for St.Eso excursion.</p><p><strong>Key results: </strong>Median duration of St.Eso excursion was 2.35 [1.93,2.85, 5th and 95th percentile] seconds. Mean maximum extent of St.Eso excursion was 2.84 ± 0.72 cm. We identified four distinct periods in deglutitive St.Eso motor function: P1. Anterosuperior ascent without bolus or peristaltic activity, P2. Non-peristaltic bolus receiving at the apogee of St.Eso excursion concurrent with UES opening and pharyngeal peristalsis P3. Peristaltic bolus transport as St.Eso descends and P4. Continued peristalsis in resting position.</p><p><strong>Conclusions and inferences: </strong>1. St.Eso motor function spans both pharyngeal and esophageal phases of swallowing for receiving and transporting the bolus, 2. Pressure signatures in HRM recordings currently attributed to St.Eso deglutitive motor activity does not represent the entirety of St.Eso peristalsis, only the part that occurs in its resting position. St.Eso peristalsis that occurs during its descent is recorded by pressure sensors initially in the pharynx. This finding needs to be considered when interpreting HRM recordings of the pharynx and proximal esophagus.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14920"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overweight/bowel dysmotility crosslinking and analogous laxative actions of two edible wild fruits in obese/constipated rats. 两种可食用野果对肥胖/便秘大鼠的超重/肠道运动障碍交联和类似通便作用。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-30 DOI: 10.1111/nmo.14933
Soumaya Wahabi, Kais Rtibi, Chirine Brinsi, Mourad Jridi, Hichem Sebai

Background: The prompt development of obesity/constipation is the most serious problem for both children and adults. Limited studies suggested an association between them but lacked preclinical studies. This study allows to evaluate their crosslink and to compare the aqueous extracts laxative actions of two edible wild fruits of Arbutus unedo (AUAE) and Crataegus monogyna (CMAE) in constipated high-fat diet (HFD) rats.

Methods: Wistar rats were divided into experimental groups for 13 weeks: standard (SD) and HFD groups. SD-rats were randomly redivided into 2 groups: SD and SD + Loperamide (LOP, 3 mg/kg, b.w.). HFD-rats were randomly reseparated into HFD-group, (HFD + LOP)-group, [HFD + Yohimbine (YOH, 2 mg/kg, b.w.)]-group, [HFD+ LOP]-groups+ various doses of AUAE or CMAE (75, 150, and 300 mg/kg, b.w.). Diversified indicators were investigated to achieve the expected objectives, including; fecal parameters, gastrointestinal transit (GIT), gastric emptying (GE), oxidative stress-(OxS), blood biochemical analysis, and accompanied small/large bowel histological modification.

Key results: The liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS) analysis of AUAE and CMAE allowed the identification of 11 and 6 phenolic compounds, respectively. In HFD-rats, the subsequent dysregulation of GI motility was markedly aggravated. More importantly, with the same way (CMAE and AUAE)-treated groups showed alleviated outcomes for the following: most stool parameters, GIT, and GE were remarkably recovered; a similar recovery pattern was observed in the histopathological structure, OxS, and blood biochemical indicators.

Conclusions & inferences: Our results experimentally confirmed the crosslink between overweight and constipation and both fruits have potential as functional foods to reduce metabolic risk of the obesity associated with bowel dysmotility.

背景:肥胖/便秘的迅速发展是儿童和成人面临的最严重问题。有限的研究表明它们之间存在联系,但缺乏临床前研究。本研究评估了它们之间的交叉联系,并比较了两种可食用野果 Arbutus unedo(AUAE)和 Crataegus monogyna(CMAE)的水提取物对高脂饮食(HFD)便秘大鼠的通便作用:将 Wistar 大鼠分为标准组(SD)和高脂饮食组(HFD),实验时间为 13 周。SD 组大鼠随机再分为 2 组:SD 组和 SD + 洛哌丁胺(LOP,3 mg/kg,b.w.)组。HFD大鼠随机再分为HFD组、(HFD + LOP)组、[HFD +育亨宾(YOH,2 mg/kg,b.w.)]组、[HFD + LOP]组+不同剂量的AUAE或CMAE(75、150和300 mg/kg,b.w.)。为达到预期目标,研究了多种指标,包括粪便参数、胃肠道转运(GIT)、胃排空(GE)、氧化应激(OxS)、血液生化分析以及伴随的小肠/大肠组织学改变:液相色谱-电喷雾离子化-串联质谱(LC-ESI-MS)分析 AUAE 和 CMAE,分别鉴定出 11 种和 6 种酚类化合物。在高氟酸膳食大鼠中,随后的消化道运动失调明显加剧。更重要的是,用同样的方法(CMAE 和 AUAE)处理的大鼠组在以下方面表现出缓解的结果:大多数粪便参数、胃肠道和 GE 显著恢复;在组织病理学结构、OxS 和血液生化指标方面也观察到类似的恢复模式:我们的研究结果通过实验证实了超重与便秘之间的交叉联系,这两种水果都具有作为功能性食品的潜力,可降低与肠道运动障碍相关的肥胖代谢风险。
{"title":"Overweight/bowel dysmotility crosslinking and analogous laxative actions of two edible wild fruits in obese/constipated rats.","authors":"Soumaya Wahabi, Kais Rtibi, Chirine Brinsi, Mourad Jridi, Hichem Sebai","doi":"10.1111/nmo.14933","DOIUrl":"10.1111/nmo.14933","url":null,"abstract":"<p><strong>Background: </strong>The prompt development of obesity/constipation is the most serious problem for both children and adults. Limited studies suggested an association between them but lacked preclinical studies. This study allows to evaluate their crosslink and to compare the aqueous extracts laxative actions of two edible wild fruits of Arbutus unedo (AUAE) and Crataegus monogyna (CMAE) in constipated high-fat diet (HFD) rats.</p><p><strong>Methods: </strong>Wistar rats were divided into experimental groups for 13 weeks: standard (SD) and HFD groups. SD-rats were randomly redivided into 2 groups: SD and SD + Loperamide (LOP, 3 mg/kg, b.w.). HFD-rats were randomly reseparated into HFD-group, (HFD + LOP)-group, [HFD + Yohimbine (YOH, 2 mg/kg, b.w.)]-group, [HFD+ LOP]-groups+ various doses of AUAE or CMAE (75, 150, and 300 mg/kg, b.w.). Diversified indicators were investigated to achieve the expected objectives, including; fecal parameters, gastrointestinal transit (GIT), gastric emptying (GE), oxidative stress-(OxS), blood biochemical analysis, and accompanied small/large bowel histological modification.</p><p><strong>Key results: </strong>The liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS) analysis of AUAE and CMAE allowed the identification of 11 and 6 phenolic compounds, respectively. In HFD-rats, the subsequent dysregulation of GI motility was markedly aggravated. More importantly, with the same way (CMAE and AUAE)-treated groups showed alleviated outcomes for the following: most stool parameters, GIT, and GE were remarkably recovered; a similar recovery pattern was observed in the histopathological structure, OxS, and blood biochemical indicators.</p><p><strong>Conclusions & inferences: </strong>Our results experimentally confirmed the crosslink between overweight and constipation and both fruits have potential as functional foods to reduce metabolic risk of the obesity associated with bowel dysmotility.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14933"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model. 神经紧张素受体 1 激动剂 PD149163 可减轻大鼠肠易激综合征模型的内脏超敏反应和结肠高渗透性。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-24 DOI: 10.1111/nmo.14925
Tsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura

Background: An impaired intestinal barrier with the activation of corticotropin-releasing factor (CRF), Toll-like receptor 4 (TLR4), and proinflammatory cytokine signaling, resulting in visceral hypersensitivity, is a crucial aspect of irritable bowel syndrome (IBS). The gut exhibits abundant expression of neurotensin; however, its role in the pathophysiology of IBS remains uncertain. This study aimed to clarify the effects of PD149163, a specific agonist for neurotensin receptor 1 (NTR1), on visceral sensation and gut barrier in rat IBS models.

Methods: The visceral pain threshold in response to colonic balloon distention was electrophysiologically determined by monitoring abdominal muscle contractions, while colonic permeability was measured by quantifying absorbed Evans blue in colonic tissue in vivo in adult male Sprague-Dawley rats. We employed the rat IBS models, i.e., lipopolysaccharide (LPS)- and CRF-induced visceral hypersensitivity and colonic hyperpermeability, and explored the effects of PD149163.

Key results: Intraperitoneal PD149163 (160, 240, 320 μg kg-1) prevented LPS (1 mg kg-1, subcutaneously)-induced visceral hypersensitivity and colonic hyperpermeability dose-dependently. It also prevented the gastrointestinal changes induced by CRF (50 μg kg-1, intraperitoneally). Peripheral atropine, bicuculline (a GABAA receptor antagonist), sulpiride (a dopamine D2 receptor antagonist), astressin2-B (a CRF receptor subtype 2 [CRF2] antagonist), and intracisternal SB-334867 (an orexin 1 receptor antagonist) reversed these effects of PD149163 in the LPS model.

Conclusions and inferences: PD149163 demonstrated an improvement in visceral hypersensitivity and colonic hyperpermeability in rat IBS models through the dopamine D2, GABAA, orexin, CRF2, and cholinergic pathways. Activation of NTR1 may modulate these gastrointestinal changes, helping to alleviate IBS symptoms.

背景:肠道屏障受损,促肾上腺皮质激素释放因子 (CRF)、Toll 样受体 4 (TLR4) 和促炎细胞因子信号被激活,导致内脏过敏,这是肠易激综合征 (IBS) 的一个重要方面。肠道中表达了大量的神经紧张素,但其在肠易激综合征病理生理学中的作用仍不确定。本研究旨在阐明神经紧张素受体 1(NTR1)的特异性激动剂 PD149163 对大鼠肠易激综合征模型的内脏感觉和肠道屏障的影响:方法:通过监测腹肌收缩,电生理测定大鼠对结肠球囊扩张反应的内脏痛阈值;通过量化成年雄性 Sprague-Dawley 大鼠体内结肠组织吸收的伊文思蓝,测量结肠通透性。我们采用了大鼠肠易激综合征模型,即脂多糖(LPS)和 CRF 诱导的内脏超敏反应和结肠高通透性,并探讨了 PD149163 的作用:腹腔注射PD149163(160、240、320 μg kg-1)可剂量依赖性地防止LPS(1 mg kg-1,皮下注射)诱导的内脏超敏反应和结肠高渗透性。它还能防止 CRF(50 μg kg-1,腹腔注射)引起的胃肠道变化。外周阿托品、双谷氨酸(一种 GABAA 受体拮抗剂)、舒必利(一种多巴胺 D2 受体拮抗剂)、 astressin2-B(一种 CRF 受体亚型 2 [CRF2] 拮抗剂)和腹腔内 SB-334867(一种奥曲肽 1 受体拮抗剂)逆转了 PD149163 在 LPS 模型中的这些作用:PD149163通过多巴胺D2、GABAA、奥曲肽、CRF2和胆碱能通路改善了大鼠肠易激综合征模型的内脏超敏性和结肠高渗透性。激活 NTR1 可调节这些胃肠道变化,有助于缓解肠易激综合征症状。
{"title":"The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.","authors":"Tsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura","doi":"10.1111/nmo.14925","DOIUrl":"10.1111/nmo.14925","url":null,"abstract":"<p><strong>Background: </strong>An impaired intestinal barrier with the activation of corticotropin-releasing factor (CRF), Toll-like receptor 4 (TLR4), and proinflammatory cytokine signaling, resulting in visceral hypersensitivity, is a crucial aspect of irritable bowel syndrome (IBS). The gut exhibits abundant expression of neurotensin; however, its role in the pathophysiology of IBS remains uncertain. This study aimed to clarify the effects of PD149163, a specific agonist for neurotensin receptor 1 (NTR1), on visceral sensation and gut barrier in rat IBS models.</p><p><strong>Methods: </strong>The visceral pain threshold in response to colonic balloon distention was electrophysiologically determined by monitoring abdominal muscle contractions, while colonic permeability was measured by quantifying absorbed Evans blue in colonic tissue in vivo in adult male Sprague-Dawley rats. We employed the rat IBS models, i.e., lipopolysaccharide (LPS)- and CRF-induced visceral hypersensitivity and colonic hyperpermeability, and explored the effects of PD149163.</p><p><strong>Key results: </strong>Intraperitoneal PD149163 (160, 240, 320 μg kg<sup>-1</sup>) prevented LPS (1 mg kg<sup>-1</sup>, subcutaneously)-induced visceral hypersensitivity and colonic hyperpermeability dose-dependently. It also prevented the gastrointestinal changes induced by CRF (50 μg kg<sup>-1</sup>, intraperitoneally). Peripheral atropine, bicuculline (a GABA<sub>A</sub> receptor antagonist), sulpiride (a dopamine D<sub>2</sub> receptor antagonist), astressin<sub>2</sub>-B (a CRF receptor subtype 2 [CRF<sub>2</sub>] antagonist), and intracisternal SB-334867 (an orexin 1 receptor antagonist) reversed these effects of PD149163 in the LPS model.</p><p><strong>Conclusions and inferences: </strong>PD149163 demonstrated an improvement in visceral hypersensitivity and colonic hyperpermeability in rat IBS models through the dopamine D<sub>2</sub>, GABA<sub>A</sub>, orexin, CRF<sub>2</sub>, and cholinergic pathways. Activation of NTR1 may modulate these gastrointestinal changes, helping to alleviate IBS symptoms.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14925"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142308209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic classification systems for disorders of gut-brain interaction should include psychological symptoms. 肠脑交互紊乱的诊断分类系统应包括心理症状。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-25 DOI: 10.1111/nmo.14940
Michael P Jones, Gerald J Holtmann, Jan Tack, Florencia Carbonne, William Chey, Natasha Koloski, Ayesha Shah, Shrikant I Bangdiwala, Ami D Sperber, Olafur S Palsson, Nicholas J Talley

Background and aims: The group of disorders known as Disorders of Gut Brain Interaction (DGBI) were originally labeled functional GI disorders and were thought to be disorders of the gastrointestinal tract that had several psychological conditions as comorbidities. Despite mounting evidence that psychological morbidity plays an innate role in the etiology and maintenance of DGBI, none of the Rome IV criteria include any measure of psychological symptoms. This study tested the hypothesis that individuals would cluster differently if GI symptoms alone were considered versus GI symptoms combined with measures of psychological symptoms.

Methods: Data were obtained from the Rome Foundation Global Epidemiology Study measuring Rome IV GI symptoms, psychological measures and demographic characteristics. Latent profile models were used to cluster individuals based on (i) GI symptoms only (GI only) and then (ii) GI and psychological measures (GI + Psych).

Key results: Individuals clustering into the same group of individuals whether formed via GI only or GI + Psych, ranged from 96% for a 2-class solution (the most simplistic) to 76% with 6 classes (the parsimonious system) and 59% with twenty-two classes (mimicking Rome IV). The generalisability of this finding between six geographic regions was confirmed with agreement varying between 95%-97% for 2 clusters and 71-79% for 6 classes and 51%-63% for 22 classes. These findings were also consistent between DGBI (range 94% with 2 classes to 50% with 22 classes) and non-DGBI (range 97% with 2 clusters to 65% with 22 classes) groups.

Conclusions & inferences: Our data suggest that considering psychological as well as gastrointestinal symptoms would lead to a different clustering of individuals in more complex, and accurate, classification systems. For this reason, future work on DGBI classification should consider inclusion of psychological traits.

背景和目的:被称为 "肠脑互动障碍"(DGBI)的一组疾病最初被称为功能性胃肠道疾病,并被认为是胃肠道疾病合并多种心理疾病。尽管有越来越多的证据表明,心理疾病在 DGBI 的病因和维持过程中起着先天性的作用,但罗马 IV 标准中却没有任何一项包含对心理症状的测量。本研究对以下假设进行了测试:如果仅考虑消化道症状,与将消化道症状与心理症状相结合,个体的聚类会有所不同:方法:数据来自罗马基金会全球流行病学研究(Rome Foundation Global Epidemiology Study),该研究测量了罗马IV型消化道症状、心理测量和人口特征。主要结果:根据(i)仅有胃肠道症状(仅有胃肠道症状)和(ii)胃肠道症状和心理测量(胃肠道症状 + 心理),使用潜伏特征分析模型对个体进行聚类:主要结果:无论是仅根据胃肠道症状还是根据胃肠道症状+心理症状,个体聚类为同一群体的比例从两类解决方案(最简单的)的 96%到 6 类解决方案(最合理的系统)的 76%,以及 22 类解决方案(模拟罗马四)的 59%不等。这一发现在六个地理区域之间的普遍性得到了证实,2 个群组的吻合率为 95%-97%,6 个等级的吻合率为 71%-79%,22 个等级的吻合率为 51%-63%。这些结果在 DGBI(2 个班级为 94%,22 个班级为 50%)和非 DGBI(2 个班级为 97%,22 个班级为 65%)组之间也是一致的:我们的数据表明,考虑心理症状和胃肠道症状将导致在更复杂、更准确的分类系统中对个体进行不同的聚类。因此,未来的 DGBI 分类工作应考虑纳入心理特征。
{"title":"Diagnostic classification systems for disorders of gut-brain interaction should include psychological symptoms.","authors":"Michael P Jones, Gerald J Holtmann, Jan Tack, Florencia Carbonne, William Chey, Natasha Koloski, Ayesha Shah, Shrikant I Bangdiwala, Ami D Sperber, Olafur S Palsson, Nicholas J Talley","doi":"10.1111/nmo.14940","DOIUrl":"10.1111/nmo.14940","url":null,"abstract":"<p><strong>Background and aims: </strong>The group of disorders known as Disorders of Gut Brain Interaction (DGBI) were originally labeled functional GI disorders and were thought to be disorders of the gastrointestinal tract that had several psychological conditions as comorbidities. Despite mounting evidence that psychological morbidity plays an innate role in the etiology and maintenance of DGBI, none of the Rome IV criteria include any measure of psychological symptoms. This study tested the hypothesis that individuals would cluster differently if GI symptoms alone were considered versus GI symptoms combined with measures of psychological symptoms.</p><p><strong>Methods: </strong>Data were obtained from the Rome Foundation Global Epidemiology Study measuring Rome IV GI symptoms, psychological measures and demographic characteristics. Latent profile models were used to cluster individuals based on (i) GI symptoms only (GI only) and then (ii) GI and psychological measures (GI + Psych).</p><p><strong>Key results: </strong>Individuals clustering into the same group of individuals whether formed via GI only or GI + Psych, ranged from 96% for a 2-class solution (the most simplistic) to 76% with 6 classes (the parsimonious system) and 59% with twenty-two classes (mimicking Rome IV). The generalisability of this finding between six geographic regions was confirmed with agreement varying between 95%-97% for 2 clusters and 71-79% for 6 classes and 51%-63% for 22 classes. These findings were also consistent between DGBI (range 94% with 2 classes to 50% with 22 classes) and non-DGBI (range 97% with 2 clusters to 65% with 22 classes) groups.</p><p><strong>Conclusions & inferences: </strong>Our data suggest that considering psychological as well as gastrointestinal symptoms would lead to a different clustering of individuals in more complex, and accurate, classification systems. For this reason, future work on DGBI classification should consider inclusion of psychological traits.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14940"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI. 症状困扰和生活干扰支持罗马临床标准,是与 DGBI 临床相关的指标。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-06 DOI: 10.1111/nmo.14936
Yao Coitinho Biurra, Colette Naude, Sara H Marchese, Subhadra Evans, Emily Barber, Elesha Parigi, Suiyin Cheah, Olafur Palsson, Ami D Sperber, Jan Tack, Douglas Drossman, Antonina Mikocka-Walus, Tiffany Taft

Background: Irritable bowel syndrome (IBS) and functional dyspepsia (FD) are common disorders of gut-brain interaction (DGBI). The Rome IV criteria are the gold standard for research when diagnosing DGBI. However, bothersomeness, or the degree to which symptoms are distressing or disruptive to a person's daily life, is a potential treatment-seeking motivator that is not assessed by the Rome criteria. The Rome Foundation developed and published diagnostic criteria for clinical practice that include bothersomeness. We aimed to evaluate these constructs via patient focus groups to determine what prompts healthcare-seeking as a means to assess its value in the Rome clinical criteria.

Methods: Adults meeting Rome IV criteria for IBS, FD, or both participated in focus groups in Australia and the United States. Semi-structured interview transcripts were analyzed using Template Thematic Analysis, with three a priori and other a posteriori themes refined iteratively through team discussion and consensus.

Key results: Participants confirmed the frequency and duration of symptoms was not sufficient to reflect illness experience. Four major themes emerged: (1) Bothersomeness should be included in assessments of IBS and FD; (2) Patients find many DGBI symptoms bothersome; (3) Bothersomeness traverses multiple domains of quality of life; (4) Patients may hesitate to seek medical advice due to past negative experiences.

Conclusions and inferences: These findings support the value of the Rome Clinical Criteria. They emphasize the importance of expanding assessments of patients with DGBI to include how bothersome they perceive symptoms to be, how much symptoms interfere with their daily life, and what may moderate their decisions to seek treatment.

背景:肠易激综合征(IBS)和功能性消化不良(FD)是常见的肠脑交互障碍(DGBI)。在诊断 DGBI 时,罗马 IV 标准是研究的黄金标准。然而,困扰,或症状对患者日常生活的困扰或干扰程度,是一种潜在的寻求治疗的动机,而罗马标准并未对其进行评估。罗马基金会制定并发布了临床实践诊断标准,其中包括困扰性。我们的目的是通过患者焦点小组对这些概念进行评估,以确定是什么促使患者寻求医疗服务,从而评估其在罗马临床标准中的价值:方法:符合罗马IV标准的肠易激综合征(IBS)、腹泻(FD)或两者兼有的成年人参加了澳大利亚和美国的焦点小组。采用模板主题分析法对半结构化访谈记录进行分析,通过小组讨论和达成共识,反复提炼出三个先验主题和其他后验主题:主要结果:参与者证实,症状的频率和持续时间不足以反映疾病的经历。得出了四大主题:(1)肠易激综合征和腹泻的评估应包括 "烦扰";(2)患者发现许多 DGBI 症状令人烦恼;(3)"烦扰 "贯穿生活质量的多个领域;(4)由于过去的负面经历,患者在寻求医疗建议时可能会犹豫不决:这些研究结果支持《罗马临床标准》的价值。结论和推论:这些研究结果支持了罗马临床标准的价值,并强调了扩大对 DGBI 患者评估的重要性,以包括他们认为症状有多令人烦恼、症状对其日常生活的干扰程度,以及哪些因素可能会影响他们寻求治疗的决定。
{"title":"Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI.","authors":"Yao Coitinho Biurra, Colette Naude, Sara H Marchese, Subhadra Evans, Emily Barber, Elesha Parigi, Suiyin Cheah, Olafur Palsson, Ami D Sperber, Jan Tack, Douglas Drossman, Antonina Mikocka-Walus, Tiffany Taft","doi":"10.1111/nmo.14936","DOIUrl":"10.1111/nmo.14936","url":null,"abstract":"<p><strong>Background: </strong>Irritable bowel syndrome (IBS) and functional dyspepsia (FD) are common disorders of gut-brain interaction (DGBI). The Rome IV criteria are the gold standard for research when diagnosing DGBI. However, bothersomeness, or the degree to which symptoms are distressing or disruptive to a person's daily life, is a potential treatment-seeking motivator that is not assessed by the Rome criteria. The Rome Foundation developed and published diagnostic criteria for clinical practice that include bothersomeness. We aimed to evaluate these constructs via patient focus groups to determine what prompts healthcare-seeking as a means to assess its value in the Rome clinical criteria.</p><p><strong>Methods: </strong>Adults meeting Rome IV criteria for IBS, FD, or both participated in focus groups in Australia and the United States. Semi-structured interview transcripts were analyzed using Template Thematic Analysis, with three a priori and other a posteriori themes refined iteratively through team discussion and consensus.</p><p><strong>Key results: </strong>Participants confirmed the frequency and duration of symptoms was not sufficient to reflect illness experience. Four major themes emerged: (1) Bothersomeness should be included in assessments of IBS and FD; (2) Patients find many DGBI symptoms bothersome; (3) Bothersomeness traverses multiple domains of quality of life; (4) Patients may hesitate to seek medical advice due to past negative experiences.</p><p><strong>Conclusions and inferences: </strong>These findings support the value of the Rome Clinical Criteria. They emphasize the importance of expanding assessments of patients with DGBI to include how bothersome they perceive symptoms to be, how much symptoms interfere with their daily life, and what may moderate their decisions to seek treatment.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14936"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of capsaicin on esophageal peristalsis in humans using high resolution manometry. 使用高分辨率测压法研究辣椒素对人体食管蠕动的影响。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-09 DOI: 10.1111/nmo.14942
Wei-Yi Lei, Jui-Sheng Hung, Ming-Wun Wong, Tso-Tsai Liu, Chih-Hsun Yi, C Prakash Gyawali, Chien-Lin Chen

Background: Capsaicin-containing red pepper sauce suspension augments esophageal contraction amplitude on conventional manometry. This study used high-resolution manometry (HRM) to investigate if capsaicin infusion modulates segmental esophageal smooth muscle peristalsis in healthy adults.

Methods: Sixteen healthy volunteers (mean age 37 years, 14 male) underwent HRM for the evaluation of primary peristalsis and secondary peristalsis using slow and rapid air distensions. Both primary and secondary peristalsis were assessed following infusions of capsaicin-containing red pepper sauce and saline.

Key results: Capsaicin infusion significantly increased heartburn symptoms compared to saline infusion (p < 0.001), and significantly decreased threshold volumes of secondary peristalsis during rapid air distensions (p = 0.02). The frequency of secondary peristalsis during rapid air distensions was significantly increased by capsaicin infusion (p = 0.03). Neither capsaicin infusion (p = 0.06) nor saline infusion (p = 0.27) altered threshold volume during slow air distensions. Capsaicin infusion significantly increased distal contractile integral (DCI) of primary peristalsis (p = 0.04), particularly in the proximal smooth muscle segment (p = 0.048). It enhanced secondary peristalsis during rapid air distensions (p = 0.003) but not during slow air distension (p = 0.23). Saline infusion significantly increased DCI of secondary peristalsis during rapid air distension (p = 0.01).

Conclusions and inferences: Augmentation of distension-induced secondary peristalsis can be modulated by activation of capsaicin-sensitive afferents similar to mechanosensitive afferents. Capsaicin-induced augmentation of primary peristalsis isolates to the cholinergic-mediated proximal smooth muscle segment, which warrants study in ineffective esophageal motility to determine therapeutic potential.

背景:含辣椒素的红辣椒酱悬浮液可通过传统测压法增强食管收缩幅度。本研究使用高分辨率测压法(HRM)来研究辣椒素注射是否会调节健康成年人的食管平滑肌节段性蠕动:方法:16 名健康志愿者(平均年龄 37 岁,男性 14 人)接受了高分辨率测压,通过缓慢和快速空气扩张来评估原发性蠕动和继发性蠕动。在输注含辣椒素的红辣椒酱和生理盐水后,对原发性和继发性蠕动进行了评估:主要结果:与输注生理盐水相比,输注辣椒素会明显加重胃灼热症状(p 结论和推论:胀气诱发的继发性蠕动可通过激活辣椒素敏感传入进行调节,这与机械敏感传入类似。辣椒素诱导的原发性蠕动增强与胆碱能介导的近端平滑肌区段分离,这值得对无效食管运动进行研究,以确定治疗潜力。
{"title":"Effects of capsaicin on esophageal peristalsis in humans using high resolution manometry.","authors":"Wei-Yi Lei, Jui-Sheng Hung, Ming-Wun Wong, Tso-Tsai Liu, Chih-Hsun Yi, C Prakash Gyawali, Chien-Lin Chen","doi":"10.1111/nmo.14942","DOIUrl":"10.1111/nmo.14942","url":null,"abstract":"<p><strong>Background: </strong>Capsaicin-containing red pepper sauce suspension augments esophageal contraction amplitude on conventional manometry. This study used high-resolution manometry (HRM) to investigate if capsaicin infusion modulates segmental esophageal smooth muscle peristalsis in healthy adults.</p><p><strong>Methods: </strong>Sixteen healthy volunteers (mean age 37 years, 14 male) underwent HRM for the evaluation of primary peristalsis and secondary peristalsis using slow and rapid air distensions. Both primary and secondary peristalsis were assessed following infusions of capsaicin-containing red pepper sauce and saline.</p><p><strong>Key results: </strong>Capsaicin infusion significantly increased heartburn symptoms compared to saline infusion (p < 0.001), and significantly decreased threshold volumes of secondary peristalsis during rapid air distensions (p = 0.02). The frequency of secondary peristalsis during rapid air distensions was significantly increased by capsaicin infusion (p = 0.03). Neither capsaicin infusion (p = 0.06) nor saline infusion (p = 0.27) altered threshold volume during slow air distensions. Capsaicin infusion significantly increased distal contractile integral (DCI) of primary peristalsis (p = 0.04), particularly in the proximal smooth muscle segment (p = 0.048). It enhanced secondary peristalsis during rapid air distensions (p = 0.003) but not during slow air distension (p = 0.23). Saline infusion significantly increased DCI of secondary peristalsis during rapid air distension (p = 0.01).</p><p><strong>Conclusions and inferences: </strong>Augmentation of distension-induced secondary peristalsis can be modulated by activation of capsaicin-sensitive afferents similar to mechanosensitive afferents. Capsaicin-induced augmentation of primary peristalsis isolates to the cholinergic-mediated proximal smooth muscle segment, which warrants study in ineffective esophageal motility to determine therapeutic potential.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14942"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction. 肠胃病医生对肠道-大脑相互作用紊乱患者进行心理社会评估的入门指南。
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-12 DOI: 10.1111/nmo.14894
Sarah Ballou, Dipesh H Vasant, Livia Guadagnoli, Bonney Reed, Giuseppe Chiarioni, Liesbeth Ten Cate, Laurie Keefer, Sarah W Kinsinger

Background: GI-specific psychological factors are important contributors to patients' symptom experience and quality of life across all disorders of gut-brain interaction (DGBI). Clinicians' ability to recognize the role of these psychological factors is essential for formulating a biopsychosocial case conceptualization and informing treatment decisions.

Purpose: This article will familiarize gastroenterology providers with conceptualizing the role of GI-specific psychological factors in DGBI and provides stepwise, practical guidance for how to assess these during clinical encounters in a time-efficient manner.

背景:肠道-脑相互作用(DGBI)疾病患者的症状体验和生活质量与肠道-脑相互作用疾病患者的症状体验和生活质量息息相关。目的:本文将帮助消化内科医生熟悉消化道特异性心理因素在 DGBI 中的作用,并为如何在临床诊疗过程中以省时高效的方式评估这些心理因素提供循序渐进的实用指导。
{"title":"A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction.","authors":"Sarah Ballou, Dipesh H Vasant, Livia Guadagnoli, Bonney Reed, Giuseppe Chiarioni, Liesbeth Ten Cate, Laurie Keefer, Sarah W Kinsinger","doi":"10.1111/nmo.14894","DOIUrl":"10.1111/nmo.14894","url":null,"abstract":"<p><strong>Background: </strong>GI-specific psychological factors are important contributors to patients' symptom experience and quality of life across all disorders of gut-brain interaction (DGBI). Clinicians' ability to recognize the role of these psychological factors is essential for formulating a biopsychosocial case conceptualization and informing treatment decisions.</p><p><strong>Purpose: </strong>This article will familiarize gastroenterology providers with conceptualizing the role of GI-specific psychological factors in DGBI and provides stepwise, practical guidance for how to assess these during clinical encounters in a time-efficient manner.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14894"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distal contractile integral and other key predictors of mean nocturnal baseline impedance: The role of esophageal peristaltic vigor in mucosal permeability. 远端收缩积分和夜间平均基线阻抗的其他关键预测因素:食管蠕动活力在粘膜通透性中的作用
IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-06 DOI: 10.1111/nmo.14937
Ofer Z Fass, Afrin N Kamal, Yan Jiang, John O Clarke

Background: Understanding the relationship between distal contractile integral (DCI) and mean nocturnal baseline impedance (MNBI) could shed light on new diagnostic and treatment strategies, specifically concerning nocturnal reflux. This study aimed to assess this relationship to enhance our comprehension of the interplay between esophageal contractility and mucosal permeability.

Methods: We identified adult patients who had high resolution esophageal manometry and pH-impedance tests performed within a 30-day period between December 2018 and March 2022. A random forest model was used to identify significant predictors of MNBI, assisting with variable selection for a following regression analysis. Subsequently, both univariable and multivariable regression models were utilized to measure the association between predictors and MNBI.

Key results: Our study included 188 patients, primarily referred for testing due to reflux. The most common motility diagnoses were normal (62%) followed by possible esophagogastric junction outflow obstruction (22%). The mean DCI was 2020 mmHg∙s∙cm and MNBI was 3.05 kΩ. The random forest model identified 12 significant predictors for MNBI, key variables being acid exposure time (AET), total proximal reflux events, intraabdominal lower esophageal sphincter length, hiatal hernia presence, and DCI. Subsequent multivariable regression analyses demonstrated log AET (β = -0.69, p = <0.001), total proximal reflux events (β = -0.16, p = 0.008), hiatal hernia presence (β = -0.82, p = 0.014), log DCI (β = 1.26, p < 0.001), and age (β = -0.13, p = 0.036) as being significantly associated with MNBI.

Conclusions and inferences: DCI is a key manometric predictor of MNBI emphasizing the role of manometry in detecting reflux risk and the need for its consideration in reflux management.

背景:了解远端收缩力积分(DCI)和夜间平均基线阻抗(MNBI)之间的关系有助于制定新的诊断和治疗策略,特别是有关夜间反流的策略。本研究旨在评估这种关系,以加深我们对食管收缩力和粘膜通透性之间相互作用的理解:我们确定了在 2018 年 12 月至 2022 年 3 月的 30 天内进行过高分辨率食管测压和 pH 阻抗测试的成年患者。我们使用随机森林模型来识别 MNBI 的重要预测因素,从而帮助选择变量进行后续回归分析。随后,利用单变量和多变量回归模型来衡量预测因素与 MNBI 之间的关联:我们的研究纳入了 188 名患者,他们主要因反流而转诊接受检查。最常见的运动诊断是正常(62%),其次是可能的食管胃交界处流出道梗阻(22%)。平均 DCI 为 2020 mmHg∙s∙cm,MNBI 为 3.05 kΩ。随机森林模型确定了 12 个重要的 MNBI 预测因子,主要变量包括酸暴露时间 (AET)、近端反流事件总数、腹腔内食管下端括约肌长度、食管裂孔疝的存在和 DCI。随后的多变量回归分析表明对数 AET(β = -0.69,p = 结论和推论:DCI是预测MNBI的一个关键测压指标,强调了测压在检测反流风险中的作用,以及在反流管理中考虑DCI的必要性。
{"title":"Distal contractile integral and other key predictors of mean nocturnal baseline impedance: The role of esophageal peristaltic vigor in mucosal permeability.","authors":"Ofer Z Fass, Afrin N Kamal, Yan Jiang, John O Clarke","doi":"10.1111/nmo.14937","DOIUrl":"10.1111/nmo.14937","url":null,"abstract":"<p><strong>Background: </strong>Understanding the relationship between distal contractile integral (DCI) and mean nocturnal baseline impedance (MNBI) could shed light on new diagnostic and treatment strategies, specifically concerning nocturnal reflux. This study aimed to assess this relationship to enhance our comprehension of the interplay between esophageal contractility and mucosal permeability.</p><p><strong>Methods: </strong>We identified adult patients who had high resolution esophageal manometry and pH-impedance tests performed within a 30-day period between December 2018 and March 2022. A random forest model was used to identify significant predictors of MNBI, assisting with variable selection for a following regression analysis. Subsequently, both univariable and multivariable regression models were utilized to measure the association between predictors and MNBI.</p><p><strong>Key results: </strong>Our study included 188 patients, primarily referred for testing due to reflux. The most common motility diagnoses were normal (62%) followed by possible esophagogastric junction outflow obstruction (22%). The mean DCI was 2020 mmHg∙s∙cm and MNBI was 3.05 kΩ. The random forest model identified 12 significant predictors for MNBI, key variables being acid exposure time (AET), total proximal reflux events, intraabdominal lower esophageal sphincter length, hiatal hernia presence, and DCI. Subsequent multivariable regression analyses demonstrated log AET (β = -0.69, p = <0.001), total proximal reflux events (β = -0.16, p = 0.008), hiatal hernia presence (β = -0.82, p = 0.014), log DCI (β = 1.26, p < 0.001), and age (β = -0.13, p = 0.036) as being significantly associated with MNBI.</p><p><strong>Conclusions and inferences: </strong>DCI is a key manometric predictor of MNBI emphasizing the role of manometry in detecting reflux risk and the need for its consideration in reflux management.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14937"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurogastroenterology and Motility
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1